Webinar & podcast
30 January 2026
Webinar - From Discovery to Clinic: Translation Biomarkers for Precision Oncology
Join Our Exclusive Webinar: "From Discovery to Clinic: Translation Biomarkers for Precision Oncology"
📅 Date: February 27, 2026 | 🕑 Time: 3:30 PM CET | 📍Live Online
Clinical trials often fail because patients aren’t selected based on their molecular profile. In this webinar, you'll explore how precision oncology and biomarkers are reshaping drug development. Learn why liquid biopsies and cfDNA/RNA fragments are emerging as essential tools for non-invasive patient stratification.
Immagina Biotechnology invites you to an exclusive webinar:
"From Discovery to Clinic: Translation Biomarkers for Precision Oncology."
✔️ What you will learn:
- Why many clinical trials fail and how better patient selection can improve outcomes
- The journey of precision oncology, from early discoveries to today’s breakthroughs
- What biomarkers are and why they matter for clinical trials and drug development
- The growing need for non-invasive tools like liquid biopsies in cancer research
- How cell-free DNA and RNA fragments are improving diagnostics, with an introduction to DOORs, Immagina’s RNA fragment detection platform
🎤 Speaker:
Alessia Del Piano, R&D Project Manager at Immagina BioTechnology
👩🔬Who should attend?
Academic researchers, biotech & pharma professionals, molecular biologists, and translatomics enthusiasts!